CS9001478A2 - Injection drug form on base of luteolytically active analogue of f2 alpha prostaglandin - Google Patents

Injection drug form on base of luteolytically active analogue of f2 alpha prostaglandin

Info

Publication number
CS9001478A2
CS9001478A2 CS147890A CS147890A CS9001478A2 CS 9001478 A2 CS9001478 A2 CS 9001478A2 CS 147890 A CS147890 A CS 147890A CS 147890 A CS147890 A CS 147890A CS 9001478 A2 CS9001478 A2 CS 9001478A2
Authority
CS
Czechoslovakia
Prior art keywords
luteolytically
base
drug form
injection drug
active analogue
Prior art date
Application number
CS147890A
Other languages
Czech (cs)
Other versions
CS276790B6 (en
Inventor
Zdenka Ing Mrvova
Eva Ing Drncova
Vladislav Rndr Csc Kubelka
Jaroslav Doc Ing Csc Palecek
Original Assignee
Leciva S P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leciva S P filed Critical Leciva S P
Priority to CS147890A priority Critical patent/CS276790B6/en
Publication of CS9001478A2 publication Critical patent/CS9001478A2/en
Publication of CS276790B6 publication Critical patent/CS276790B6/en

Links

CS147890A 1990-03-27 1990-03-27 Injectable dosage form based on the luteolytically active prostaglandin analogue F2 alpha CS276790B6 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS147890A CS276790B6 (en) 1990-03-27 1990-03-27 Injectable dosage form based on the luteolytically active prostaglandin analogue F2 alpha

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS147890A CS276790B6 (en) 1990-03-27 1990-03-27 Injectable dosage form based on the luteolytically active prostaglandin analogue F2 alpha

Publications (2)

Publication Number Publication Date
CS9001478A2 true CS9001478A2 (en) 1991-10-15
CS276790B6 CS276790B6 (en) 1992-08-12

Family

ID=5349292

Family Applications (1)

Application Number Title Priority Date Filing Date
CS147890A CS276790B6 (en) 1990-03-27 1990-03-27 Injectable dosage form based on the luteolytically active prostaglandin analogue F2 alpha

Country Status (1)

Country Link
CS (1) CS276790B6 (en)

Also Published As

Publication number Publication date
CS276790B6 (en) 1992-08-12

Similar Documents

Publication Publication Date Title
FI872917A0 (en) PHARMACEUTICAL BAERARE, VILKA FRIGOER AKTIVAEMNET REGLERBART.
SE8903042D0 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING CYCLOSPORINS
ATE222243T1 (en) PHARMACEUTICALLY ACTIVE BENZOQUINAZOLINE COMPOUNDS
NO903941D0 (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE DIAZEPINON DERIVATIVES.
NO172575C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BENZOCYCLYLKANE DERIVATIVES
IL92837A0 (en) 7-oxabicycloheptyl substituted heterocyclic prostaglandin analogs and pharmaceutical compositions containing the same
ZA906383B (en) Long active injectable formulations containing triacetin
FI925869L (en) FOERFARANDE FOER INFOERANDE AV EN PEPTID I CYTOSOL
ITMI911101A0 (en) ACTIVE DRUG IN AUTOIMMUNE DISEASES
CS9001478A2 (en) Injection drug form on base of luteolytically active analogue of f2 alpha prostaglandin
IT8805224A0 (en) POLYESTER-BASED COMPOSITION FOR THE CONTROLLED RELEASE OF MEDICINAL SUBSTANCES.
CS9001479A2 (en) Injection drug form on base of luteolytically active analogue of prostaglandin
NO168586C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE DIAZEPINON COMPOUNDS
CS383890A3 (en) Pharmaceutical with a controllable bio-disposal of active component
GB9121220D0 (en) Stable production of m-csf active polypeptide
AP9000164A0 (en) Improved formulation of law-dose interferon alpha
IT1205109B (en) PHARMACEUTICAL COMPOSITIONS WITH IMMUNOMODULATING ACTIVITY
IT1219429B (en) PHARMACEUTICAL COMPOSITIONS WITH ANTIPROLACTIN ACTIVITY
KR970005836B1 (en) Pharmaceutical composition of phenyl carbamate for subcutaneous administration
CS283689A3 (en) Injection medicinal form based on prostaglandin e 2
CS631190A3 (en) E1 prostaglandin in injection medicinal form
HU906379D0 (en) Producing active substance of medicament
CS363890A3 (en) Medicament form with controlled release of active component
GB8721749D0 (en) Administration of pharmacologically active substances
IT1223316B (en) PHARMACEUTICAL COMPOSITIONS FOR ORAL USE BASED ON ENZYMES WITH PROTEOLYTIC ACTIVITY

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MM4A Patent lapsed due to non-payment of fee

Effective date: 20000327